Paper Review Records
全部论文审稿周期
25 篇有效样本 · 按发表日期由新到旧排列
审稿天数=录用日期-收稿日期;保留 PDF/DOI/网页源链接
251
天
Cytotoxic activity of selinexor in BRAF V600E -driven pediatric low-grade glioma 3D cultures
作者
Constantia Zeiser; Marta Emperador; Sonja Herter; Lisa Sigaud; Alexandra Stroh-Dege; Anna Loboda; Anna Kolodziejczak; Simon Zeuner; Lea Joy Digel; Karen Frese; Bruno Chilian; Micaela Freitas; Jens M. Kelm; Ingrid Ǿra; Daniel Vogl; Martin Ulrich Schuhmann; Heike Peterziel; Romain Sigaud; Florian Selt; Till Milde; Olaf Witt; Ina Oehme展开收起
作者单位
1. Hopp Children’s Cancer Center Heidelberg (KiTZ), Heidelberg, Germany; 2. Clinical Cooperation Unit Pediatric Oncology, German Cancer Research Center (DKFZ) and German Cancer Consortium (DKTK), Heidelberg, Germany; 3. National Center for Tumor Diseases (NCT), NCT Heidelberg, Heidelberg University Hospital, Heidelberg, Germany; 4. Faculty of Medicine, Heidelberg University, Heidelberg, Germany; 5. Faculty of Biosciences, Heidelberg University, Heidelberg, Germany; 6. Department of Pediatric Oncology, Hematology, Immunology and Pulmonology, Heidelberg University Hospital, Heidelberg, Germany; 7. Department of Medicine III, Heidelberg University, German Centre for Cardiovascular Research (DZHK), Heidelberg, Germany; 8. TRI Thinking Research Instruments GmbH, Hamburg, Germany; 9. Precomb Therapeutics AG, Hombrechtikon, Switzerland; 10. Lund University, Lund, Sweden; 11. Karolinska University Hospital, Stockholm, Sweden; 12. Department of Neurosurgery, Section of Pediatric Neurosurgery, University Hospital Tuebingen, Tuebingen, Germany; 13. Department of Neurosurgery, Centre of Neurofibromatosis and Schwannomatosis, Centre for Rare Diseases, Division of Pediatric Neurosurgery, University Hospital Tübingen, Tübingen, Germany; 14. Department of Pediatrics and Adolescent Medicine, University Hospital Jena, Friedrich Schiller University Jena and Comprehensive Cancer Center Central Germany (CCCG), Jena, Germany展开收起
79
天
Vascular profiling of the spinal cord and cortex reveals region-specific endothelial dysfunction and fibroblast remodeling in human ALS
作者
Kuo Liao; Jianing Lin; Yangfan Zhou; Sebastian A. Lewandowski展开收起
作者单位
1. Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden; 2. Center for Molecular Medicine, Karolinska University Hospital, Stockholm, Sweden展开收起
116
天
Altered oligodendroglial cell development and increased myelination in SCN2A gain-of-function-linked epilepsy
作者
Constanza Bravo-Rossainz Baez; Xian Xin; Hang Lyu; Daniil Kirianov; Ying Sun; Erik Späte; Mariapia Grassia; Birgit Engeland; Malte Stockebrand; Konstantin Khodosevich; Ulrike B. S. Hedrich; Dirk Isbrandt; Friederike Pfeiffer展开收起
作者单位
1. Department of Neurophysiology, Institute of Physiology, University of Tübingen, Tübingen, Germany; 2. Biotech Research and Innovation Centre (BRIC), Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark; 3. Department of Neurology and Epileptology, Hertie Institute for Clinical Brain Research, University of Tuebingen, Tübingen, Germany; 4. Deutsches Zentrum Für Neurodegenerative Erkrankungen (DZNE), Bonn, Germany; 5. Institute for Molecular and Behavioral Neuroscience and Center for Molecular Medicine Cologne, University of Cologne, Cologne, Germany; 6. Werner Reichardt Centre for Integrative Neuroscience, University of Tübingen, Tübingen, Germany展开收起
129
天
The superior prognostic role of pRB1 over p16 immunohistochemistry as a biomarker in meningiomas
作者
Hanna Gött; Jonas Tellermann; Hannes Becker; Christina Fodi; Peter Paßlack; Elgin Hoffmann; Maria Elisa Di Francesco; Daniel J. Merk; Jürgen Honegger; Ghazaleh Tabatabai; Marcos Tatagiba; Felix Behling; Jens Schittenhelm展开收起
作者单位
1. Center for Neuro-Oncology, Comprehensive Cancer Center Tübingen-Stuttgart, University Hospital Tübingen, Eberhard-Karls-University Tübingen, Tübingen, Germany; 2. Department of Neurosurgery, University Hospital Tübingen, Eberhard-Karls-University Tübingen, Tübingen, Germany; 3. Department of Neurology and Interdisciplinary Neuro-Oncology, University Hospital Tübingen, Eberhard-Karls-University Tübingen, Tübingen, Germany; 4. Cluster of Excellence (EXC 2180) “Image Guided and Functionally Instructed Tumor Therapies”, Eberhard-Karls University Tübingen, Tübingen, Germany; 5. Department of Anesthesiology, University Hospital Tübingen, Eberhard-Karls-University Tübingen, Tübingen, Germany; 6. Department of Radiation Oncology, University Hospital Tübingen, Eberhard-Karls-University Tübingen, Tübingen, Germany; 7. Department of Ophthalmology, Inselspital Bern, University of Bern, Bern, Switzerland; 8. German Cancer Consortium (DKTK), DKFZ Partner Site Tübingen, Tübingen, Germany; 9. Department of Neurosurgery, Faculty of Medicine, Augsburg University, Augsburg, Germany; 10. Translational Oncological Neurosurgery, Faculty of Medicine, University Augsburg, Augsburg, Germany; 11. Department of Neuropathology, Institute of Pathology and Neuropathology, University Hospital Tübingen, Eberhard-Karls-University Tübingen, Tübingen, Germany展开收起
113
天
A standardized framework resolves ambiguity in motor neuron loss across neurodegenerative diseases
作者
Leonie Sowoidnich; Aaron L. Norman; Florian Gerstner; Josiane K. Siemund; Jannik M. Buettner; John G. Pagiazitis; Vanessa Dreilich; Konstantin Pilz; Dajun Tian; Charlotte J. Sumner; Angela Paradis; George Z. Mentis; Christian M. Simon展开收起
作者单位
1. Carl-Ludwig-Institute for Physiology, Leipzig University, Leipzig, Germany; 2. Center for Motor Neuron Biology and Disease, Columbia University, New York, USA; 3. Depts. of Pathology and Cell Biology and Neurology, Columbia University, New York, USA; 4. Biogen, Cambridge, USA; 5. Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, USA; 6. Department of Neuroscience, Johns Hopkins University School of Medicine, Baltimore, USA; 7. Department of Genetic Medicine, Johns Hopkins University School of Medicine, Baltimore, USA展开收起
71
天
Age-associated epigenomic heterogeneity in papillary tumors of the pineal region: a multicenter YoungNOA investigation
作者
Lazaros Lazaridis; Xiaomei Zhou; Raphael Bodensohn; Malte Mohme; Julia Onken; Regina von Manitius; Naomi Houedjissin; Tobias Blau; Ilinca Popp; Sarina Agkatsev; Sabine Seidel; Christina Schaub; Maximilian Scheer; Andre Sagerer; Volker Neuschmelting; Davide Tosin; Viktoria Ruf; Michael C. Burger; Christoph Oster; Teresa Schmidt; Benjamin Thiele; Jürgen Hench; Stephan Frank; Martin Stuschke; Laurèl Rauschenbach; Stephan Tippelt; Beate Timmermann; Kathy Keyvani; Clemens Seidel; Andrea Tannapfel; Dorothea Miller; Niklas Thon; Joachim P. Steinbach; Elke Pfaff; Georg Karpel-Massler; Jörg Felsberg; Guido Reifenberger; Marcos Tatagiba; Ghazaleh Tabatabai; Jens Schittenhelm; Christian Thomas; Martin Hasselblatt; Corinna Seliger; Christoph Kleinschnitz; Ulrich Sure; David Capper; Michael Platten; Felix Behling; Michael Müther; Sied Kebir展开收起
作者单位
1. Department of Neurology, University Hospital Knappschaftskrankenhaus Bochum, Ruhr University Bochum, Bochum, Germany; 2. Division of Clinical Neuro-Oncology, Department of Neurology and Center for Translational Neuro- and Behavioral Sciences (C-TNBS), University Medicine Essen, University Duisburg-Essen, Essen, Germany; 3. Department of Radiation Oncology, University Hospital Tübingen, Tübingen, Germany; 4. Department of Neurosurgery, University Medical Center Hamburg-Eppendorf, Hamburg, Germany; 5. Department of Neurosurgery, Charité - Universitätsmedizin Berlin, Berlin, Germany; 6. Department of Neuropathology, Charité - Universitätsmedizin Berlin, Berlin, Germany; 7. Department of Neurosurgery, Medical Faculty, Center of Neuro-Oncology, Heinrich-Heine-University Düsseldorf, Düsseldorf, Germany; 8. Institute of Neuropathology, University Medicine Essen, Essen, Germany; 9. Department of Radiation Oncology, Medical Center-University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany; 10. Department of Neurooncology, Centers for Neurology and Integrated Oncology (CIO), University Hospital Bonn, Bonn, Germany; 11. Department of Neurosurgery, University Hospital Heidelberg, Heidelberg, Germany; 12. Department of Neurosurgery, Universität Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany; 13. Department of General Neurosurgery, Center for Neurosurgery, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany; 14. Department of Neurological Surgery, Ulm University Medical Center, Ulm, Germany; 15. Faculty of Medicine, Center for Neuropathology and Prion Research, LMU Munich, Munich, Germany; 16. Goethe University, Dr. Senckenberg Institute of Neurooncology, Goethe University Hospital, Frankfurt Am Main, Germany; 17. German Cancer Consortium (DKTK), Partner Site Essen/Düsseldorf, a Partnership Between DKFZ and University Hospital Essen, Germany, DKFZ-Division Translational Neuro-Oncology at the West German Cancer Center (WTZ), University Medicine Essen, University Duisburg-Essen, Essen, Germany; 18. Medical Oncology, University Hospital Basel, Basel, Switzerland; 19. Laboratory of Translational Immuno-Oncology, Department of Biomedicine, University and University Hospital Basel, Basel, Switzerland; 20. Institute for Pathology and Medical Genetics, University Hospital Basel, Basel, Switzerland; 21. Department of Radiotherapy, University Medicine Essen, University Duisburg-Essen, Essen, Germany; 22. Department of Neurosurgery and Spine Surgery, University Medicine Essen, University Duisburg-Essen, Essen, Germany; 23. Department of Pediatrics III, Center for Translational Neuro- and Behavioral Sciences (C-TNBS), University Hospital of Essen, Essen, Germany; 24. Department of Particle Therapy, University Hospital Essen, West German Proton Therapy Centre Essen (WPE), West German Cancer Centre (WTZ), Essen, Germany; 25. German Cancer Consortium (DKTK), Essen, Germany; 26. Department of Radiotherapy and Radiation Oncology, University Hospital Leipzig, Leipzig, Germany; 27. Institute of Pathology, Ruhr University Bochum, Bochum, Germany; 28. Department of Neurosurgery, University Hospital Knappschaftskrankenhaus Bochum, Ruhr University Bochum, Bochum, Germany; 29. Department of Pediatric Oncology, Hematology and Immunology, Heidelberg University Hospital, Heidelberg, Germany; 30. Institute of Neuropathology, Medical Faculty, Heinrich-Heine-University Düsseldorf, and University Hospital Düsseldorf, Düsseldorf, Germany; 31. Department of Neurosurgery, University Hospital Tübingen, Tübingen, Germany; 32. Department of Neurology and Interdisciplinary Neuro-Oncology, University Hospital Tübingen, Hertie Institute for Clinical Brain Research, Center for Neuro-Oncology, Comprehensive Cancer Center, Eberhard-Karls-University Tübingen, Tübingen, Germany; 33. Department of Neuropathology, Institute of Pathology and Neuropathology, University Hospital Tübingen, Eberhard-Karls-University Tübingen, Tübingen, Germany; 34. Institute of Neuropathology, University Hospital Münster, Münster, Germany; 35. German Cancer Consortium (DKTK), Partner Site Berlin, and German Cancer Research Center (DKFZ), Heidelberg, Germany; 36. Department of Neurology, Medical Faculty Mannheim, Mannheim Center for Translational Neurosciences (MCTN), University of Heidelberg, Mannheim, Germany; 37. Department of Neurosurgery, Faculty of Medicine, University of Augsburg, Augsburg, Germany; 38. Department of Neurosurgery, University Hospital Münster, Münster, Germany展开收起
Expert Matching · Case Demo
把投稿要求,转成可验证的期刊方案
说清专业、时限和作者背景,CrushSCI 结合真实审稿样本,给出拟题方向、期刊初筛与周期判断。
